Arcadia Biosciences, Inc. — Director's Dealing 2017

Jun 10, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2017-06-07

Reporting Person: Rey Eric J. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	141680	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.08	2018-06-30	Common Stock (520104)		Direct
Stock Option (right to buy)	$2.24	2019-11-01	Common Stock (137500)		Direct
Stock Option (right to buy)	$2.24	2020-01-01	Common Stock (187500)		Direct
Stock Option (right to buy)	$13.56	2021-01-01	Common Stock (125000)		Direct
Stock Option (right to buy)	$13.56	2022-12-31	Common Stock (25000)		Direct
Stock Option (right to buy)	$6.12	2024-10-29	Common Stock (25000)		Direct

Footnotes

F1: The option is fully exercisable as of the date hereof.